The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...

AstraZeneca PLC AZN shares inched down 0.05% to £109.82 Friday, on what proved to be an all-around dismal trading session for ...

AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank ...

Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both have generally produced strong financial results in 2024, but one wouldn ...

The Motley Fool recommends AstraZeneca Plc and Novo Nordisk. The Motley Fool has a disclosure policy. Making the world smarter, happier, and richer.

IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a disabled person An IT worker has won a legal battle to sue AstraZeneca ...

Achilles Therapeutics plc has announced the transfer of data and samples from its TRACERx Non-Small Cell Lung Cancer study and its Material Acquisition Platform (MAP) to AstraZeneca for a total ...

Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, has entered into a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo for the treatment of ...

Oncology 2023 Congress and the IASLC 2024 World Conference on Lung Cancer, with simultaneous publication in the Journal of Clinical Oncology in September 2024. AstraZeneca, a global ...

AstraZeneca PLC (LSE/STO/NASDAQ: LON:AZN), a leading biopharmaceutical company with a market capitalization of $206.73 billion, today announced the appointment of Rene Haas and Birgit Conix as Non ...